| scholarly article | Q13442814 |
| P50 | author | Florian Herse | Q47804678 |
| Kedra Wallace | Q56256861 | ||
| Gerd Wallukat | Q63288594 | ||
| Ralf Dechend | Q63812628 | ||
| Janae Moseley | Q122375952 | ||
| P2093 | author name string | Jeremy Scott | |
| Babbette LaMarca | |||
| Denise C Cornelius | |||
| James P Hogg | |||
| P2860 | cites work | Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F | Q24296262 |
| Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity | Q33894387 | ||
| Recent insights into the pathophysiology of preeclampsia | Q34404445 | ||
| Recent Insights into the pathogenesis of pre-eclampsia | Q34682287 | ||
| Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes | Q35029700 | ||
| CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy | Q35130793 | ||
| Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction | Q35576417 | ||
| IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy | Q36178540 | ||
| Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia | Q36380482 | ||
| The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy | Q36407259 | ||
| Mechanisms of disease: Pre-eclampsia | Q36577103 | ||
| The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia | Q37088970 | ||
| Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
| Deciphering the role of Th17 cells in human disease | Q37940695 | ||
| Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia | Q46332630 | ||
| IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. | Q50715057 | ||
| Effects of reduced uterine perfusion pressure on blood pressure and metabolic factors in pregnant rats. | Q51470693 | ||
| IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. | Q51687384 | ||
| Emerging roles of antiangiogenic and angiogenic proteins in pathogenesis and prediction of preeclampsia | Q61845360 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Pathophysiology of pregnancy-induced hypertension | Q74039094 | ||
| Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia | Q83391804 | ||
| Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension | Q83799951 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | arterial hypertension | Q41861 |
| interleukins | Q194908 | ||
| P304 | page(s) | 1068-1073 | |
| P577 | publication date | 2013-09-23 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy | |
| P478 | volume | 62 |
| Q28069689 | A Dormant Microbial Component in the Development of Preeclampsia |
| Q92010061 | Adaptive Immunity in Hypertension |
| Q91826774 | Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways |
| Q92670725 | Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker? |
| Q35116086 | Autoimmunity: an underlying factor in the pathogenesis of hypertension |
| Q28083815 | Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia |
| Q41056432 | Circulating Th1, Th2, and Th17 Levels in Hypertensive Patients. |
| Q33606181 | Dual opposing roles of adaptive immunity in hypertension |
| Q64913619 | Evaluation of blood vessel injury, oxidative stress and circulating inflammatory factors in an L-NAME-induced preeclampsia-like rat model. |
| Q40779892 | Hypertension in an Animal Model of HELLP Syndrome is Associated With Activation of Endothelin 1. |
| Q57772657 | Hypertension: a new treatment for an old disease? Targeting the immune system |
| Q36997267 | IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia |
| Q39182623 | IL-17 mediates neutrophil infiltration and renal fibrosis following recovery from ischemia reperfusion: compensatory role of natural killer cells in athymic rats |
| Q37139722 | Identifying immune mechanisms mediating the hypertension during preeclampsia |
| Q89860687 | Inflammasomes-A Molecular Link for Altered Immunoregulation and Inflammation Mediated Vascular Dysfunction in Preeclampsia |
| Q26827586 | Inflammation and hypertension: new understandings and potential therapeutic targets |
| Q26827525 | Inflammation, immunity, and hypertensive end-organ damage |
| Q37483159 | Magnesium Sulfate Prevents Placental Ischemia-Induced Increases in Brain Water Content and Cerebrospinal Fluid Cytokines in Pregnant Rats |
| Q46342648 | Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia |
| Q37136212 | Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia |
| Q58589187 | Molecular Determinants of Microvascular Dysfunction in Hypertensive Pregnancy and Preeclampsia |
| Q47637232 | Natural killer cells mediate pathophysiology in response to reduced uterine perfusion pressure |
| Q27303128 | Neutrophil Depletion Attenuates Placental Ischemia-Induced Hypertension in the Rat |
| Q39018896 | Oxidative Stress and Hypertensive Diseases |
| Q38641180 | Oxidative Stress: Placenta Function and Dysfunction |
| Q92071244 | Placental CD4+ T cells isolated from preeclamptic women cause preeclampsia-like symptoms in pregnant nude-athymic rats |
| Q37451544 | Placental Ischemia and Resultant Phenotype in Animal Models of Preeclampsia |
| Q36357583 | Placental ischemia increases seizure susceptibility and cerebrospinal fluid cytokines |
| Q88542480 | Placental ischemia-stimulated T-helper 17 cells induce preeclampsia-associated cytolytic natural killer cells during pregnancy |
| Q88194244 | Postpartum increases in cerebral edema and inflammation in response to placental ischemia during pregnancy |
| Q57055935 | Pre-eclampsia: the role of highly active antiretroviral therapy and immune markers |
| Q48523077 | Preeclampsia: From Inflammation to Immunoregulation |
| Q26800272 | Preeclampsia: long-term consequences for vascular health |
| Q38691672 | Proliferation of endogenous regulatory T cells improve the pathophysiology associated with placental ischaemia of pregnancy |
| Q45848306 | Reduced uterine perfusion pressure T-helper 17 cells cause pathophysiology associated with preeclampsia during pregnancy |
| Q35801516 | Role of IL-17 Variants in Preeclampsia in Chinese Han Women |
| Q47630406 | Role of Immune Factors in Angiotensin II-Induced Hypertension and Renal Damage in Dahl Salt-Sensitive Rats |
| Q34713771 | Sex differences in T cells in hypertension |
| Q37385038 | TH17- and IL-17- mediated autoantibodies and placental oxidative stress play a role in the pathophysiology of pre-eclampsia |
| Q47630395 | Th17 cells contribute to pulmonary fibrosis and inflammation during chronic kidney disease progression following acute ischemia |
| Q93164620 | The Expression of IL-12 Family Members in Patients with Hypertension and Its Association with the Occurrence of Carotid Atherosclerosis |
| Q33834419 | The role of inflammation in the pathology of preeclampsia |
Search more.